Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Gilead Sciences, Inc. et al v. Aurobindo Pharma Ltd. et al
Case Number:
1:18-cv-00765
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
October 09, 2018
Gilead, Indian Generic Co. Drop Truvada Infringement Suit
Gilead Sciences Inc. has asked a Delaware federal court to dismiss yet another patent infringement case against a drugmaker attempting to sell a generic version of its blockbuster HIV preventative medication Truvada, with hints that a settlement is being hammered out.
-
May 21, 2018
Gilead Again Pushes To Block Truvada Generic
Gilead Sciences Inc. and Emory University accused Aurobindo Pharma Ltd. in Delaware federal court Friday of infringing two of their patents covering the HIV treatment Truvada, the latest in a series of lawsuits attempting to block a generic version of the blockbuster drug.